Safety Strategies for Biobanks

Safety for Biobanks: Strategies for Safe COVID-19 Specimens Handling

The COVID-19 pandemic has spread to almost every country around the world. In less than 4 months, this new disease has affected more than 1,800,000 people and caused almost 120,000 deaths. There are no effective treatments or vaccines for...

Virtual Biobanking Trends and Challenges in COVID-19 Pandemic Era

In the last three decades, biobanks have evolved significantly all over the globe and recognized as an increasingly important source of data for medical research since the late 1990s. Having developed from freezer farms to rich data repositories, biobanks...

SARS-CoV-2 Detected In French Biobank Sample Collected In Late 2019

COVID-19 is a respiratory disease pandemic that has swept across the world, causing over 282,495 deaths (May 10, 2020). Patients most commonly present at hospitals with influenza-like illness (ILI). The causative agent of COVID-19, the coronavirus SARS-CoV-2, has no...

What can Biobanks Learn From the Current Pandemic?

More than a year ago, something happened that most of us could hardly imagine. A virus took the whole world more or less firmly in its grip. Pandemic, previously a word that very few of us knew, has now...

CloudLIMS Offers Free LIMS Globally to SARS-CoV-2 & COVID-19 Research & Testing Laboratories, and...

Wilmington, Delaware – March 21, 2020. CloudLIMS recognizes the threat to global health the COVID-19 pandemic brings. To do our part, we are making our flagship in the cloud LIMS (Laboratory Information Management System), CloudLIMS Enterprise, free of charge...

CloudLIMS Redefines Operations in COVID-19 Biobanks with its Ready-to-go-live COVID-19 LIMS

Wilmington, Delaware – May 08, 2020, CloudLIMS, a leading provider of laboratory informatics, announces the launch of a ready-to-go-live COVID-19 LIMS. CloudLIMS is preconfigured with CDC approved COVID-19 biorepository SOPs and can be quickly set up in less than a week. With...

ISBER Releases Position Statement for Management and Use of Ultra Low Temperature Freezers

The International Society for the Biological and Environmental Repositories (ISBER), which represents professional experts in biobanking, ultra-low temperature (ULT) storage and cold chain management, has released its position statement listing key practices health agencies should consider to support the...

Identification, Biobanking, and Large-Scale Production of SARS-CoV-2-Specific Memory T Lymphocytes From COVID-19 Convalescent Donors

The infectious disease with a wide and diverse range of symptoms known as COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged as a worldwide pandemic in late 2019. In most infected patients, the virus causes mild...

Vitamin D Status Did Not Predict COVID-19 Infection Risk In The UK Biobank

A recent meta-analysis of 25 clinical trials located in 15 countries conducted by the UK National Health Service (NHS), Institute for Health Research, indicated that vitamin D supplements reduced the risk of acute respiratory infection (ARI) from 42% to...

Complement And Coagulation Disorders Associated With COVID-19

Recent structure based comparisons suggest that coronavirus proteins mimic at least 140 human proteins, including those in the complement and coagulation pathways. The complement cascade leading to cell death and inflammation is part of the innate immune system, and...

⭐ Recently Featured

🔥 Popular Posts

X